DAO and early-onset autosomal dominant Alzheimer disease: Although most research focusses on these agents enhancing cognition in psychiatric disorders [5, 111], current findings are pertinent to disorders, like Alzheimer’s disease [112, 113], where plasma D-amino acid oxidase levels correlate with cognitive decline [114] but other work suggests that elevated brain D-serine occurs in Alzheimer’s [112].